Effects of prior osteoporosis treatment on the treatment response of romosozumab followed by denosumab in patients with postmenopausal osteoporosis
Sign Up to like & getrecommendations! Published in 2022 at "Osteoporosis International"
DOI: 10.1007/s00198-022-06386-y
Abstract: In patients with postmenopausal osteoporosis, prior osteoporosis treatment affected the bone mineral density increase of following treatment with 12 months of romosozumab, although it did not affect that of following treatment with 12 months of… read more here.
Keywords: patients postmenopausal; osteoporosis treatment; treatment; osteoporosis ... See more keywords
Status quo of osteoporosis treatment in Japan disclosed by the National Database of Health Insurance Claims and Specific Health Checkups: too late in treatment initiation and too few in treated patients?
Sign Up to like & getrecommendations! Published in 2019 at "Archives of Osteoporosis"
DOI: 10.1007/s11657-019-0637-7
Abstract: SummaryFor the first time ever, the details of osteoporotic treatment were unveiled through the big data published by the government of Japan. The number of patients being treated is low and treatment start is late,… read more here.
Keywords: treatment; national database; bisphosphonates denosumab; osteoporosis treatment ... See more keywords
Effect of osteoporosis treatment agents on the cortical bone osteocyte microenvironment in adult estrogen-deficient, osteopenic rats
Sign Up to like & getrecommendations! Published in 2018 at "Bone Reports"
DOI: 10.1016/j.bonr.2018.02.005
Abstract: Though osteoporosis is a significant cause of disability worldwide, treatment with pharmacologic agents decreases risk of fragility fracture. Though these treatments act through the bone remodeling system to improve bone mass, it is unclear if… read more here.
Keywords: treatment; matrix; bone; osteoporosis treatment ... See more keywords
Update on osteoporosis treatment.
Sign Up to like & getrecommendations! Published in 2018 at "Medicina Clinica"
DOI: 10.1016/j.medcle.2018.03.011
Abstract: Treatment of osteoporosis should be directed primarily towards secondary prevention of fractures. The occurrence of drug-related adverse effects for the treatment of osteoporosis has led to a reevaluation of the indications, the duration of treatment… read more here.
Keywords: treatment; update osteoporosis; osteoporosis treatment; vertebral fractures ... See more keywords
Implications of guidelines for osteoporosis and its treatment.
Sign Up to like & getrecommendations! Published in 2018 at "Age and ageing"
DOI: 10.1093/ageing/afx197
Abstract: The development of clinical guidelines is now a more uniform process, with formalised methods to ensure that recommendations are based on current best available evidence from randomised controlled trials and systematic reviews. Over the past… read more here.
Keywords: fracture risk; risk; treatment; osteoporosis treatment ... See more keywords
Uptake of osteoporosis treatment recommended by an orthogeriatrics service after hip fracture: Retrospective cohort study of prevalence and potential barriers and enablers at a tertiary referral hospital in Sydney.
Sign Up to like & getrecommendations! Published in 2022 at "Australasian journal on ageing"
DOI: 10.1111/ajag.13048
Abstract: OBJECTIVES The primary aim was to determine the 12-month period prevalence of and time to osteoporosis treatment following minimal trauma hip fractures in patients who were recommended treatment by an orthogeriatrics service. The secondary aim… read more here.
Keywords: hip; service; osteoporosis treatment; treatment ... See more keywords
Osteoporosis management in Australian general practice: an analysis of current osteoporosis treatment patterns and gaps in practice
Sign Up to like & getrecommendations! Published in 2020 at "BMC Family Practice"
DOI: 10.1186/s12875-020-01103-2
Abstract: Background Among Australians aged 50 and over, an estimated 1 in 4 men and 2 in 5 women will experience a minimal trauma fracture during their remaining lifetime. Effective fracture prevention is hindered by substantial… read more here.
Keywords: general practice; practice; osteoporosis treatment; osteoporosis management ... See more keywords
Utilization of screening and treatment for osteoporosis among stroke survivors
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Endocrinology"
DOI: 10.3389/fendo.2022.1043863
Abstract: Background Stroke survivors are prone to osteoporosis and fractures. However, bone mineral density (BMD) testing and osteoporosis treatment were underutilized in patients with recent stroke. We aimed to examine whether stroke has an impact on… read more here.
Keywords: bmd testing; testing osteoporosis; osteoporosis treatment; osteoporosis ... See more keywords
Antioxidant Carboxymethyl Chitosan Carbon Dots with Calcium Doping Achieve Ultra-Low Calcium Concentration for Iron-Induced Osteoporosis Treatment by Effectively Enhancing Calcium Bioavailability in Zebrafish
Sign Up to like & getrecommendations! Published in 2023 at "Antioxidants"
DOI: 10.3390/antiox12030583
Abstract: Iron overloads osteoporosis mainly occurs to postmenopausal women and people requiring repeated blood transfusions. Iron overload increases the activity of osteoclasts and decreases the activity of osteoblasts, leading to the occurrence of osteoporosis. Conventional treatment… read more here.
Keywords: antioxidant carboxymethyl; iron; calcium; osteoporosis treatment ... See more keywords
Towards Controlling the Local Bone Tissue Remodeling—Multifunctional Injectable Composites for Osteoporosis Treatment
Sign Up to like & getrecommendations! Published in 2023 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms24054959
Abstract: Alendronate (ALN) is the most commonly prescribed oral nitrogen-containing bisphosphonate for osteoporosis therapy. However, its administration is associated with serious side effects. Therefore, the drug delivery systems (DDS) enabling local administration and localized action of… read more here.
Keywords: osteoporosis treatment; msp nh2; bone; aln ... See more keywords
Reducing the osteoporosis treatment gap: an interview with UCB's Pascale Richetta
Sign Up to like & getrecommendations! Published in 2018 at "Future Science OA"
DOI: 10.4155/fsoa-2017-0110
Abstract: Dr. Pascale Richetta is Executive Vice President and Head of the Bone Patient Value Unit at UCB (Brussels, Belgium). She joined UCB in 2016 following over 20 years’ experience in the pharma and biotech industry.… read more here.
Keywords: treatment gap; pascale richetta; gap interview; richetta ... See more keywords